Phase II study of ONYX-015 in patients with hepatobiliary tumors with p53 correlative studies

被引:0
|
作者
Wadler, S
Makower, D
Yu, B
Tan, JY
Rozenblit, A
Kaufman, H
Edelman, M
Lane, M
Zwiebel, J
Horwitz, M
机构
[1] Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY USA
[2] Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10467 USA
[3] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY USA
[4] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA
[5] Albert Einstein Coll Med, Dept Surg, Bronx, NY 10467 USA
[6] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
[7] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
468
引用
收藏
页码:S140 / S141
页数:2
相关论文
共 50 条
  • [41] Hepatic artery infusion of ONYX-015 in combination with 5-FU/leukovorin for metastatic gastrointestinal cancer metastatic to the liver: a phase I/II study.
    Reid, T
    Rubin, J
    Galanis, E
    Abbruzzese, J
    Lowe, A
    Sze, D
    Romel, L
    Kirn, D
    CLINICAL CANCER RESEARCH, 1999, 5 : 3798S - 3798S
  • [42] A CORRELATIVE STUDY OF P53 PROTEIN ALTERATION AND P53 GENE MUTATION IN GLIOBLASTOMA-MULTIFORME
    NEWCOMB, EW
    MADONIA, WJ
    PISHARODY, S
    LANG, FF
    KOSLOW, M
    MILLER, DC
    BRAIN PATHOLOGY, 1993, 3 (03) : 229 - 235
  • [43] ONYX-015: An adenovirus in the E1B-55kD gene replicates in, and causes lysis of, p53- tumor cells.
    Kirn, D
    Heise, C
    SampsonJohannes, A
    Williams, A
    Muna, M
    Trown, PW
    McCormick, F
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 119 - 119
  • [44] A phase I clinical trial with ONYX-015 (a selectively replicating adenovirus) administered by intratumoral injection in patients with recurrent head and neck carcinoma
    Kirn, D
    Ganley, I
    Nemunaitis, J
    Otto, R
    Soutar, D
    Kuhn, J
    Heise, C
    Propst, M
    Maack, C
    Eckhardt, G
    Kaye, S
    VonHoff, D
    CANCER GENE THERAPY, 1997, 4 (06) : O5 - O5
  • [45] ONYX-015: An adenovirus attenuated in the E1B-55kD gene, replicates and causes lysis in p53- tumor cells.
    Heise, C
    SampsonJohannes, A
    Williams, A
    Bischoff, J
    Muna, M
    Trown, P
    McCormick, F
    Kirn, D
    CANCER GENE THERAPY, 1996, 3 (06) : O98 - O98
  • [46] A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000)
    Ganly, I
    Kirn, D
    Eckhardt, SG
    Rodriguez, GI
    Soutar, DS
    Otto, R
    Robertson, AG
    Park, O
    Gulley, ML
    Heise, C
    VonHoff, DD
    Kaye, SB
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 754 - 754
  • [47] Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants
    Hann, B
    Balmain, A
    JOURNAL OF VIROLOGY, 2003, 77 (21) : 11588 - 11595
  • [48] Mutated p53 in tumors, mutant p53 and p53-specific antibodies in the circulation in patients with gastric cancer
    Maeta, M
    Saito, H
    Oka, S
    Tsujitani, S
    Ikeguchi, M
    Kaibara, N
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2000, 19 (04) : 489 - 495
  • [49] Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
    Senzer, Neil
    Nemunaitis, John
    Nemunaitis, Derek
    Bedell, Cynthia
    Edelman, Gerald
    Barve, Minal
    Nunan, Robert
    Pirollo, Kathleen F.
    Rait, Antonina
    Chang, Esther H.
    MOLECULAR THERAPY, 2013, 21 (05) : 1096 - 1103
  • [50] P53 MUTATION IN SOFT-TISSUE SARCOMA - A CORRELATIVE STUDY OF P53 IMMUNOREACTIVITY WITH HISTOLOGIC GRADE S-PHASE FRACTION AND DNA-PLOIDY
    LUCAS, DR
    ZALUPSKI, MM
    RYAN, JR
    RUAN, H
    NAGARAJ, M
    LABORATORY INVESTIGATION, 1995, 72 (01) : A8 - A8